Day: August 7, 2020

JERUSALEM, Aug. 07, 2020 (GLOBE NEWSWIRE) — Intec Pharma Ltd. (NASDAQ: NTEC) (“Intec” or “the Company”), today announced that it has entered into a definitive agreement with Aspire Capital Fund (“Aspire”) for the purchase and sale, in a registered direct offering, of 7,125,000 of the Company’s ordinary shares at a purchase price of $0.3511 per share, and pre-funded warrants to purchase 7,125,000 of the Company’s ordinary shares at a purchase price of $0.3411 per warrant, which represents the per warrant offering price less the $0.01 per share exercise price for each such warrant. The offering is expected to close on or about August 10, 2020, subject to satisfaction of customary closing conditions.The gross proceeds to Intec from this offering are expected to be approximately $4.9 million, before deducting a commitment fee payable...

LAKE FOREST, Ill., Aug. 07, 2020 (GLOBE NEWSWIRE) — Akorn, Inc. (The OTC Pink Market: AKRXQ), a leading specialty pharmaceutical company, today announced its financial results for the second quarter of 2020.Second Quarter 2020 Results and Recent DevelopmentsNet revenue was $120 million, down $58 million, 32% from the prior year quarterNet loss was $69 million, compared to $112 million loss in the prior year quarterAdjusted EBITDA was $(2) million, compared to $36 million in the prior year quarterFiled for Chapter 11 bankruptcy protection on May 20, 2020, and executed a Restructuring Support Agreement with lenders serving as the “stalking horse” bidder in the Company’s sale processSummary Financial Results for the Quarter Ended June 30, 2020Akorn’s reported net revenue was $120.3 million for the three month period ended...

FutureFuel Second Quarter Net Income of $15.2 MillionReports Net Income of $15.2 Million or $0.35 per Diluted Share, and Adjusted EBITDA of $2.7 MillionCLAYTON, Mo., Aug. 07, 2020 (GLOBE NEWSWIRE) — FutureFuel Corp. (NYSE:FF) (“FutureFuel”), a manufacturer of custom and performance chemicals and biofuels, today announced financial results for the second quarter and the six months ended June 30, 2020.Second quarter 2020 Financial Highlights (all comparisons are with the second quarter of 2019)Six month 2020 Financial Highlights (all comparisons are with the first half of 2019)“Our manufacturing operation has continued to perform well against the backdrop of the global COVID-19 pandemic in both our Chemical and Biofuels segments. The certainty of the Blenders’ Tax Credit has allowed us to operate our Biodiesel operation at full capacity,...

TORONTO, Aug. 07, 2020 (GLOBE NEWSWIRE) — Pinetree Capital Ltd. (TSX:PNP) (“Pinetree” or the “Company”) today announced its financial results for the three months ended June 30, 2020.  All financial information provided in this press release is unaudited and all figures are in $’000 except per share amounts and shares outstanding.Unaudited financial results for the period ended June 30, 2020The following information should be read in conjunction with our annual audited Consolidated Financial Statements, prepared in accordance with International Financial Reporting Standards (“IFRS”) and our annual Management Discussion and Analysis for the year ended December 31, 2019, which can be found on SEDAR at www.sedar.com.Selected Financial Information 1 Refer to “Use of Non-IFRS Financial Measures”Shares Outstanding and Book Value amounts...

GAITHERSBURG, Md., Aug. 07, 2020 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE:EBS) (the “Company”) announced today that it has completed its previously announced offering of $450 million in aggregate principal amount of its 3.875% Senior Unsecured Notes due 2028 (the “Notes”).The Notes are fully and unconditionally guaranteed on a senior unsecured basis by all of the Company’s direct and indirect subsidiaries that guarantee debt under its credit facilities. The Company has used the net proceeds of the offering to repay the $353 million outstanding under its $600 million revolving credit facility with the remainder to be used for general corporate purposes.The Notes were offered in the United States to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”),...

EL SEGUNDO, Calif., Aug. 07, 2020 (GLOBE NEWSWIRE) — Aerojet Rocketdyne Holdings, Inc. (NYSE:AJRD) announced today that Dan Boehle has been named as the company’s Chief Financial Officer. Boehle will report directly to CEO and President Eileen P. Drake and will be based out of the corporate headquarters in El Segundo, California.“Dan brings a wealth of expertise in corporate finance and a strong track record of driving profitable growth,” said Aerojet Rocketdyne CEO and President Eileen P. Drake. “Dan’s extensive experience and focus on delivering value for shareholders has been a tremendous asset to our company and I look forward to his leadership as our CFO.”Boehle joined Aerojet Rocketdyne in August 2017 as Vice President, Controller and Principal Accounting Officer. Over the last several years, he has led Aerojet Rocketdyne...

New York, Aug. 07, 2020 (GLOBE NEWSWIRE) — SCWorx, Corp., (Nasdaq: WORX) today announced that Nasdaq has notified it that trading in its common stock will resume on The Nasdaq Stock Market, this coming Monday, August 10, 2020.Contacts:Timothy A. Hannibalthannibal@scworx.com

NEW YORK, Aug. 07, 2020 (GLOBE NEWSWIRE) — Medley Capital Corporation (NYSE: MCC) (TASE: MCC) (the “Company”) today announced financial results for the quarter ended June 30, 2020.Third Quarter SummaryNet asset value of $149.3 million, or, $54.83 per share, vs. $141.7 million, or, $52.04 per share, at March 31, 2020Net investment loss of $(0.26) per shareFully repaid Series A Israeli Notes (the “Israeli Notes”)The board of directors did not declare a dividend this quarterPost Quarter End SummaryCompleted a one-for-twenty reverse stock split on July 24, 20201Portfolio InvestmentsThe total value of our investments was $250.6 million at June 30, 2020. During the quarter ended June 30, 2020, the Company originated $2.9 million of investments and had $17.3 million of repayments and sales, resulting in net repayments and sales of $14.4...

MONTREAL, Aug. 07, 2020 (GLOBE NEWSWIRE) — Senvest Capital Inc. today reported net income attributable to common shareholders of $161.2 million or $60.85 per share for the three months ended June 30, 2020. This compares to a net loss attributable to common shareholders of ($56.6) million or ($21.04) per share for the same period in 2019.  For the six months ended June 30, 2020, the net loss attributable to common shareholders was ($180.7) million or ($68.53) per share, compared to a net loss attributable to common shareholders of ($1.8) million or ($0.67) per share the prior year.Financial statements are available online at Sedar www.sedar.comGeorge Malikotsis, Vice President Finance(514) 281-8082